A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.

Journal of drugs in dermatology : JDD

Volumn 4, Issue 5, 2005, Pages 592-597

  Torok, Helen ^a   Taylor, Susan ^a   Baumann, Leslie ^a   Jones, Terry ^a   Wieder, Joshua ^a   Lowe, Nicholas ^a   Jarret, Michael ^a   Rich, Pheobe ^a   Pariser, David ^a   Tschen, Eduardo ^a   Martin, Dale ^a   Menter, Alan ^a   Weiss, Jonathan ^a  

^a Trillium Creek Dermatology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; FLUOCINOLONE ACETONIDE; HYDROQUINONE; HYDROQUINONE DERIVATIVE; KERATOLYTIC AGENT; RETINOIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; MALE; MELANOSIS; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FLUOCINOLONE ACETONIDE; HUMANS; HYDROQUINONES; KERATOLYTIC AGENTS; MALE; MELANOSIS; MIDDLE AGED; TRETINOIN;

EID: 27144444996     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)